These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 15878919)

  • 1. CYP17 genotype predicts serum hormone levels among pre-menopausal women.
    Small CM; Marcus M; Sherman SL; Sullivan AK; Manatunga AK; Feigelson HS
    Hum Reprod; 2005 Aug; 20(8):2162-7. PubMed ID: 15878919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The relationship between a polymorphism in CYP17 with plasma hormone levels and breast cancer.
    Haiman CA; Hankinson SE; Spiegelman D; Colditz GA; Willett WC; Speizer FE; Kelsey KT; Hunter DJ
    Cancer Res; 1999 Mar; 59(5):1015-20. PubMed ID: 10070957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytochrome P450c17alpha gene (CYP17) polymorphism is associated with serum estrogen and progesterone concentrations.
    Feigelson HS; Shames LS; Pike MC; Coetzee GA; Stanczyk FZ; Henderson BE
    Cancer Res; 1998 Feb; 58(4):585-7. PubMed ID: 9485002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CYP17 genotype is associated with short menstrual cycles, early oral contraceptive use and BRCA mutation status in young healthy women.
    Henningson M; Johansson U; Borg A; Olsson H; Jernström H
    Mol Hum Reprod; 2007 Apr; 13(4):231-6. PubMed ID: 17307805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Breast cancer risk associated with genotype polymorphism of the estrogen-metabolizing genes CYP17, CYP1A1, and COMT: a multigenic study on cancer susceptibility.
    Huang CS; Chern HD; Chang KJ; Cheng CW; Hsu SM; Shen CY
    Cancer Res; 1999 Oct; 59(19):4870-5. PubMed ID: 10519398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CYP17 5'-UTR MspA1 polymorphism and the risk of premenopausal breast cancer in a German population-based case-control study.
    Verla-Tebit E; Wang-Gohrke S; Chang-Claude J
    Breast Cancer Res; 2005; 7(4):R455-64. PubMed ID: 15987450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association between the T27C polymorphism in the cytochrome P450 c17alpha (CYP17) gene and risk factors for breast cancer.
    Hong CC; Thompson HJ; Jiang C; Hammond GL; Tritchler D; Yaffe M; Boyd NF
    Breast Cancer Res Treat; 2004 Dec; 88(3):217-30. PubMed ID: 15609124
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP17 genotypes differ in salivary 17-beta estradiol levels: a study based on hormonal profiles from entire menstrual cycles.
    Jasienska G; Kapiszewska M; Ellison PT; Kalemba-Drozdz M; Nenko I; Thune I; Ziomkiewicz A
    Cancer Epidemiol Biomarkers Prev; 2006 Nov; 15(11):2131-5. PubMed ID: 17119038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cyp17, urinary sex steroid levels and breast cancer risk in postmenopausal women.
    Onland-Moret NC; van Gils CH; Roest M; Grobbee DE; Peeters PH
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):815-20. PubMed ID: 15824149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen-metabolizing gene polymorphisms, but not estrogen receptor-alpha gene polymorphisms, are associated with the onset of menarche in healthy postmenopausal Japanese women.
    Gorai I; Tanaka K; Inada M; Morinaga H; Uchiyama Y; Kikuchi R; Chaki O; Hirahara F
    J Clin Endocrinol Metab; 2003 Feb; 88(2):799-803. PubMed ID: 12574216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dehydroepiandrosterone sulphate as a putative protective factor against tardive dyskinesia.
    Ivanova SA; Geers LM; Al Hadithy AF; Pechlivanoglou P; Semke AV; Vyalova NM; Rudikov EV; Fedorenko OY; Wilffert B; Bokhan NA; Brouwers JR; Loonen AJ
    Prog Neuropsychopharmacol Biol Psychiatry; 2014 Apr; 50():172-7. PubMed ID: 24389397
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP17 promoter polymorphism and breast cancer in Australian women under age forty years.
    Spurdle AB; Hopper JL; Dite GS; Chen X; Cui J; McCredie MR; Giles GG; Southey MC; Venter DJ; Easton DF; Chenevix-Trench G
    J Natl Cancer Inst; 2000 Oct; 92(20):1674-81. PubMed ID: 11036113
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between serum hormone concentrations, reproductive history, alcohol consumption and genetic polymorphisms in pre-menopausal women.
    García-Closas M; Herbstman J; Schiffman M; Glass A; Dorgan JF
    Int J Cancer; 2002 Nov; 102(2):172-8. PubMed ID: 12385014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two single nucleotide polymorphisms in the CYP17 and COMT Genes--relation to bone mass and longitudinal bone changes in postmenopausal women with or without hormone replacement therapy. The Danish Osteoporosis Prevention Study.
    Tofteng CL; Abrahamsen B; Jensen JE; Petersen S; Teilmann J; Kindmark A; Vestergaard P; Gram J; Langdahl BL; Mosekilde L
    Calcif Tissue Int; 2004 Aug; 75(2):123-32. PubMed ID: 15129369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CYP17 MspA1 polymorphism and breast cancer risk: a meta-analysis.
    Ye Z; Parry JM
    Mutagenesis; 2002 Mar; 17(2):119-26. PubMed ID: 11880540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A polymorphism in the CYP17 gene increases the risk of breast cancer.
    Feigelson HS; Coetzee GA; Kolonel LN; Ross RK; Henderson BE
    Cancer Res; 1997 Mar; 57(6):1063-5. PubMed ID: 9067272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CYP17 and COMT gene polymorphisms can influence bone directly, or indirectly through their effects on endogenous sex steroids, in postmenopausal Japanese women.
    Gorai I; Inada M; Morinaga H; Uchiyama Y; Yamauchi H; Hirahara F; Chaki O
    Bone; 2007 Jan; 40(1):28-36. PubMed ID: 16971197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A polymorphism in CYP17 and endometrial cancer risk.
    Haiman CA; Hankinson SE; Colditz GA; Hunter DJ; De Vivo I
    Cancer Res; 2001 May; 61(10):3955-60. PubMed ID: 11358812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The relationship between a polymorphism in CYP17 with plasma hormone levels and prostate cancer.
    Haiman CA; Stampfer MJ; Giovannucci E; Ma J; Decalo NE; Kantoff PW; Hunter DJ
    Cancer Epidemiol Biomarkers Prev; 2001 Jul; 10(7):743-8. PubMed ID: 11440959
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steroid metabolism gene CYP17 polymorphism and the development of breast cancer.
    Mitrunen K; Jourenkova N; Kataja V; Eskelinen M; Kosma VM; Benhamou S; Vainio H; Uusitupa M; Hirvonen A
    Cancer Epidemiol Biomarkers Prev; 2000 Dec; 9(12):1343-8. PubMed ID: 11142420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.